{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T16:03:03Z","timestamp":1784822583324,"version":"3.55.0"},"reference-count":105,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Blood Cells, Molecules, and Diseases"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1016\/j.bcmd.2016.10.001","type":"journal-article","created":{"date-parts":[[2016,10,19]],"date-time":"2016-10-19T09:49:38Z","timestamp":1476870578000},"page":"66-73","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":45,"special_numbering":"C","title":["Liver involvement in Gaucher disease \u2013 Review and clinical approach"],"prefix":"10.1016","volume":"68","author":[{"given":"Tomer","family":"Adar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaron","family":"Ilan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah","family":"Elstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ari","family":"Zimran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.bcmd.2016.10.001_bb0005","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/S0950-3536(97)80032-7","article-title":"Gaucher's disease: molecular, genetic and enzymological aspects","volume":"10","author":"Grabowski","year":"1997","journal-title":"Baillieres Clin. Haematol."},{"key":"10.1016\/j.bcmd.2016.10.001_bb0010","series-title":"Williams Hematology","first-page":"1065","article-title":"Lipid storage diseases","author":"Zimran","year":"2010"},{"issue":"1","key":"10.1016\/j.bcmd.2016.10.001_bb0015","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/0016-5085(81)90202-X","article-title":"LIver abnormalities in patients with Gaucher's disease","volume":"80","author":"James","year":"1981","journal-title":"Gastroenterology"},{"issue":"9","key":"10.1016\/j.bcmd.2016.10.001_bb0020","doi-asserted-by":"crossref","first-page":"2597","DOI":"10.1182\/blood.V98.9.2597","article-title":"Discrepancies between genotype and phenotype in hematology: an important frontier","volume":"98","author":"Beutler","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2016.10.001_bb0025","series-title":"Gaucher Disease: A Century of Delineation and Research","first-page":"131","article-title":"Gaucher disease: hepatic abnormalities in 25 patients","author":"James","year":"1982"},{"issue":"4","key":"10.1016\/j.bcmd.2016.10.001_bb0030","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1093\/qjmed\/93.4.237","article-title":"Massive hepatic fibrosis in Gaucher's disease: clinico-pathological and radiological features","volume":"93","author":"Lachmann","year":"2000","journal-title":"QJM"},{"issue":"6","key":"10.1016\/j.bcmd.2016.10.001_bb0035","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1182\/blood-2011-04-308890","article-title":"How I treat Gaucher disease","volume":"118","author":"Zimran","year":"2011","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.bcmd.2016.10.001_bb0040","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1002\/ajh.21369","article-title":"Enzyme replacement therapy for mild patients with Gaucher disease","volume":"84","author":"Zimran","year":"2009","journal-title":"Am. J. Hematol."},{"issue":"7","key":"10.1016\/j.bcmd.2016.10.001_bb0045","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1038\/icb.2009.42","article-title":"Glucocerebroside: an evolutionary advantage for patients with Gaucher disease and a new immunomodulatory agent","volume":"87","author":"Ilan","year":"2009","journal-title":"Immunol. Cell Biol."},{"issue":"5","key":"10.1016\/j.bcmd.2016.10.001_bb0050","first-page":"G917","article-title":"Glucocerebroside treatment ameliorates ConA hepatitis by inhibition of NKT lymphocytes","volume":"289","author":"Margalit","year":"2005","journal-title":"Am. J. Phys."},{"issue":"1","key":"10.1016\/j.bcmd.2016.10.001_bb0055","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1136\/gut.2006.095497","article-title":"Beta-glucosylceramide: a novel method for enhancement of natural killer T lymphoycte plasticity in murine models of immune-mediated disorders","volume":"56","author":"Zigmond","year":"2007","journal-title":"Gut"},{"issue":"4","key":"10.1016\/j.bcmd.2016.10.001_bb0060","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1097\/01.tp.0000252783.66886.f3","article-title":"Alleviation of acute and chronic graft-versus-host disease in a murine model is associated with glucocerebroside-enhanced natural killer T lymphocyte plasticity","volume":"83","author":"Ilan","year":"2007","journal-title":"Transplantation"},{"issue":"4","key":"10.1016\/j.bcmd.2016.10.001_bb0065","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1097\/MCG.0b013e31827873dc","article-title":"Immune therapy for nonalcoholic steatohepatitis: are we there yet?","volume":"47","author":"Ilan","year":"2013","journal-title":"J. Clin. Gastroenterol."},{"issue":"1","key":"10.1016\/j.bcmd.2016.10.001_bb0070","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1124\/jpet.106.104950","article-title":"Glucocerebroside ameliorates the metabolic syndrome in OB\/OB mice","volume":"319","author":"Margalit","year":"2006","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"1","key":"10.1016\/j.bcmd.2016.10.001_bb0075","first-page":"E72","article-title":"Beta-glycosphingolipids improve glucose intolerance and hepatic steatosis of the Cohen diabetic rat","volume":"296","author":"Zigmond","year":"2009","journal-title":"Am. J. Phys."},{"key":"10.1016\/j.bcmd.2016.10.001_bb0080","first-page":"151","article-title":"Beta-glycosphingolipids ameliorated non-alcoholic steatohepatitis in the Psammomys obesus model","volume":"7","author":"Zigmond","year":"2014","journal-title":"J. Inflamm. Res."},{"issue":"21","key":"10.1016\/j.bcmd.2016.10.001_bb0085","doi-asserted-by":"crossref","first-page":"2589","DOI":"10.1016\/j.vaccine.2008.03.026","article-title":"Beta-glycoglycosphingolipid-induced augmentation of the anti-HBV immune response is associated with altered CD8 and NKT lymphocyte distribution: a novel adjuvant for HBV vaccination","volume":"26","author":"Mizrahi","year":"2008","journal-title":"Vaccine"},{"issue":"12","key":"10.1016\/j.bcmd.2016.10.001_bb0090","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1016\/j.bbamem.2006.09.011","article-title":"Biophysics of sphingolipids I. Membrane properties of sphingosine, ceramides and other simple sphingolipids","volume":"1758","author":"Goni","year":"2006","journal-title":"Biochim. Biophys. Acta"},{"issue":"11","key":"10.1016\/j.bcmd.2016.10.001_bb0095","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.2174\/138955706778742722","article-title":"Glycolipids as immune modulatory tools","volume":"6","author":"Lalazar","year":"2006","journal-title":"Mini-Rev. Med. Chem."},{"issue":"1","key":"10.1016\/j.bcmd.2016.10.001_bb0100","doi-asserted-by":"crossref","first-page":"1R","DOI":"10.1093\/glycob\/cwl052","article-title":"Gangliosides as components of lipid membrane domains","volume":"17","author":"Sonnino","year":"2007","journal-title":"Glycobiology"},{"issue":"S1","key":"10.1016\/j.bcmd.2016.10.001_bb0105","doi-asserted-by":"crossref","first-page":"490A","DOI":"10.1016\/S0270-9139(03)80727-9","article-title":"Glucocerebroside induces altered anti hepatitis C immunity in patients with Gaucher's disease","volume":"38","author":"Margalit","year":"2003","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.bcmd.2016.10.001_bb0110","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1111\/j.1365-2141.2006.06199.x","article-title":"Aggregation of red blood cells in patients with Gaucher disease","volume":"134","author":"Adar","year":"2006","journal-title":"Br. J. Haematol."},{"issue":"2","key":"10.1016\/j.bcmd.2016.10.001_bb0115","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1046\/j.1365-2567.2003.01657.x","article-title":"Innate self recognition by an invariant, rearranged T-cell receptor and its immune consequences","volume":"109","author":"Stanic","year":"2003","journal-title":"Immunology"},{"issue":"2","key":"10.1016\/j.bcmd.2016.10.001_bb0120","doi-asserted-by":"crossref","first-page":"943","DOI":"10.4049\/jimmunol.172.2.943","article-title":"Dissociation of NKT stimulation, cytokine induction, and NK activation in vivo by the use of distinct TCR-binding ceramides","volume":"172","author":"Ortaldo","year":"2004","journal-title":"J. Immunol."},{"issue":"6","key":"10.1016\/j.bcmd.2016.10.001_bb0125","doi-asserted-by":"crossref","first-page":"3693","DOI":"10.4049\/jimmunol.173.6.3693","article-title":"Quantitative and qualitative differences in the in vivo response of NKT cells to distinct alpha- and beta-anomeric glycolipids","volume":"173","author":"Parekh","year":"2004","journal-title":"J. Immunol."},{"issue":"2","key":"10.1016\/j.bcmd.2016.10.001_bb0130","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1080\/15476910802129620","article-title":"Beta-glycosphingolipids as immune modulators","volume":"5","author":"Adar","year":"2008","journal-title":"J. Immunotoxicol."},{"issue":"1\u20132","key":"10.1016\/j.bcmd.2016.10.001_bb0135","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.jneuroim.2007.09.014","article-title":"Understanding the behavior of invariant NKT cells in autoimmune diseases","volume":"191","author":"Yamamura","year":"2007","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.bcmd.2016.10.001_bb0140","first-page":"180A","article-title":"Treatment of non-alcoholic steatohepatitis by B-glucosylceramide: a phase I\/II clinical study","volume":"44","author":"Zigmond","year":"2006","journal-title":"Hepatology"},{"issue":"7","key":"10.1016\/j.bcmd.2016.10.001_bb0145","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1002\/1521-4141(200007)30:7<1919::AID-IMMU1919>3.0.CO;2-3","article-title":"Activation of hepatic NKT cells and subsequent liver injury following administration of alpha-galactosylceramide","volume":"30","author":"Osman","year":"2000","journal-title":"Eur. J. Immunol."},{"issue":"3","key":"10.1016\/j.bcmd.2016.10.001_bb0150","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.4049\/jimmunol.175.3.1540","article-title":"Alpha-galactosylceramide-induced liver injury in mice is mediated by TNF-alpha but independent of Kupffer cells","volume":"175","author":"Biburger","year":"2005","journal-title":"J. Immunol."},{"issue":"4 Suppl 5","key":"10.1016\/j.bcmd.2016.10.001_bb0155","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1053\/j.seminhematol.2004.07.009","article-title":"Therapeutic goals in the treatment of Gaucher disease","volume":"41","author":"Pastores","year":"2004","journal-title":"Semin. Hematol."},{"key":"10.1016\/j.bcmd.2016.10.001_bb0160","first-page":"81","article-title":"Imiglucerase in the treatment of Gaucher disease: a history and perspective","volume":"6","author":"Deegan","year":"2012","journal-title":"Drug Des. Devel. Ther."},{"issue":"2","key":"10.1016\/j.bcmd.2016.10.001_bb0165","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/s003300101031","article-title":"Spectrum of abdominal sonographic findings in 103 pediatric patients with Gaucher disease","volume":"12","author":"Patlas","year":"2002","journal-title":"Eur. Radiol."},{"issue":"2","key":"10.1016\/j.bcmd.2016.10.001_bb0170","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1148\/radiology.184.2.1620865","article-title":"Gaucher disease: abdominal MR imaging findings in 46 patients","volume":"184","author":"Hill","year":"1992","journal-title":"Radiology"},{"issue":"3","key":"10.1016\/j.bcmd.2016.10.001_bb0175","doi-asserted-by":"crossref","first-page":"209","DOI":"10.7863\/jum.1997.16.3.209","article-title":"Accuracy of ultrasonography in assessing spleen and liver size in patients with Gaucher disease: comparison to computed tomographic measurements","volume":"16","author":"Elstein","year":"1997","journal-title":"J. Ultrasound Med."},{"issue":"4","key":"10.1016\/j.bcmd.2016.10.001_bb0180","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1159\/000204218","article-title":"Comparison of magnetic resonance imaging and ultrasound in evaluating liver size in Gaucher patients","volume":"92","author":"Glenn","year":"1994","journal-title":"Acta Haematol."},{"issue":"11","key":"10.1016\/j.bcmd.2016.10.001_bb0185","first-page":"569","article-title":"Focal changes of the spleen in one case of Gaucher disease\u2013assessed by ultrasonography, CT, MRI and angiography","volume":"29","author":"Aspestrand","year":"1989","journal-title":"Radiologe"},{"issue":"6","key":"10.1016\/j.bcmd.2016.10.001_bb0190","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1097\/00005792-199211000-00002","article-title":"Gaucher disease. Clinical, laboratory, radiologic, and genetic features of 53 patients","volume":"71","author":"Zimran","year":"1992","journal-title":"Medicine"},{"key":"10.1016\/j.bcmd.2016.10.001_bb0195","doi-asserted-by":"crossref","DOI":"10.1023\/A:1012496514170","article-title":"Gaucher disease: understanding the molecular pathogenesis of sphingolipidoses","volume":"24","author":"Cox","year":"2001","journal-title":"J. Inherit. Metab. Dis."},{"issue":"4","key":"10.1016\/j.bcmd.2016.10.001_bb0200","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1007\/s10545-009-1178-9","article-title":"Autopsy case of Gaucher disease type I in a patient on enzyme replacement therapy. Comments on the dynamics of persistent storage process","volume":"32","author":"Hulkova","year":"2009","journal-title":"J. Inherit. Metab. Dis."},{"issue":"2","key":"10.1016\/j.bcmd.2016.10.001_bb0205","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.ymgme.2013.09.002","article-title":"Gaucher disease: chemotactic factors and immunological cell invasion in a mouse model","volume":"111","author":"Pandey","year":"2014","journal-title":"Mol. Genet. Metab."},{"issue":"1","key":"10.1016\/j.bcmd.2016.10.001_bb0210","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1097\/00007611-199701000-00016","article-title":"Pseudo-Gaucher's cells in association with common acute lymphoblastic leukemia","volume":"90","author":"Knox-Macaulay","year":"1997","journal-title":"South. Med. J."},{"issue":"1","key":"10.1016\/j.bcmd.2016.10.001_bb0215","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1177\/1066896912456081","article-title":"Abundant hepatic Gaucher-like cells following chemotherapy and bone marrow transplantation for hematologic malignancy: report of two cases","volume":"21","author":"Stenzel","year":"2013","journal-title":"Int. J. Surg. Pathol."},{"issue":"7","key":"10.1016\/j.bcmd.2016.10.001_bb0220","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1097\/00004836-200408000-00009","article-title":"Increased prevalence of cholelithiasis in Gaucher disease: association with splenectomy but not with gilbert syndrome","volume":"38","author":"Ben Harosh-Katz","year":"2004","journal-title":"J. Clin. Gastroenterol."},{"issue":"3","key":"10.1016\/j.bcmd.2016.10.001_bb0225","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/s10545-010-9070-1","article-title":"High incidence of cholesterol gallstone disease in type 1 Gaucher disease: characterizing the biliary phenotype of type 1 Gaucher disease","volume":"33","author":"Taddei","year":"2010","journal-title":"J. Inherit. Metab. Dis."},{"issue":"5","key":"10.1016\/j.bcmd.2016.10.001_bb0230","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/S0168-8278(99)80297-9","article-title":"International autoimmune hepatitis group report: review of criteria for diagnosis of autoimmune hepatitis","volume":"31","author":"Alvarez","year":"1999","journal-title":"J. Hepatol."},{"issue":"1","key":"10.1016\/j.bcmd.2016.10.001_bb0235","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1002\/hep.22322","article-title":"Simplified criteria for the diagnosis of autoimmune hepatitis","volume":"48","author":"Hennes","year":"2008","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.bcmd.2016.10.001_bb0240","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1002\/ajh.2830290403","article-title":"Polyclonal B-cell lymphocytosis and hypergammaglobulinemia in patients with Gaucher disease","volume":"29","author":"Marti","year":"1988","journal-title":"Am. J. Hematol."},{"issue":"4 Suppl 5","key":"10.1016\/j.bcmd.2016.10.001_bb0245","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1053\/j.seminhematol.2004.07.010","article-title":"Gaucher disease type 1: revised recommendations on evaluations and monitoring for adult patients","volume":"41","author":"Weinreb","year":"2004","journal-title":"Semin. Hematol."},{"issue":"5","key":"10.1016\/j.bcmd.2016.10.001_bb0250","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0063959","article-title":"Current and future disease progression of the chronic HCV population in the United States","volume":"8","author":"Zalesak","year":"2013","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.bcmd.2016.10.001_bb0255","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/s10545-008-0779-z","article-title":"Management of non-neuronopathic Gaucher disease with special reference to pregnancy, splenectomy, bisphosphonate therapy, use of biomarkers and bone disease monitoring","volume":"31","author":"Cox","year":"2008","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.bcmd.2016.10.001_bb0260","series-title":"Recommendations for the Identification of Chronic Hepatitis C Virus Infection Among Persons Born During 1945\u20131965","article-title":"Center for disease control, morbidity and mortality weekly report","year":"2012"},{"issue":"9","key":"10.1016\/j.bcmd.2016.10.001_bb0265","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.7863\/jum.2002.21.9.1053","article-title":"Multiple hypoechoic hepatic lesions in a patient with Gaucher disease","volume":"21","author":"Patlas","year":"2002","journal-title":"J. Ultrasound Med."},{"issue":"1","key":"10.1016\/j.bcmd.2016.10.001_bb0270","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1002\/(SICI)1096-8652(199705)55:1<28::AID-AJH5>3.0.CO;2-5","article-title":"Abdominal ultrasound findings mimicking hematological malignancies in a study of 218 Gaucher patients","volume":"55","author":"Neudorfer","year":"1997","journal-title":"Am. J. Hematol."},{"issue":"3","key":"10.1016\/j.bcmd.2016.10.001_bb0275","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1002\/hep.23183","article-title":"Image of the month. Hepatic Gaucheroma mimicking focal nodular hyperplasia","volume":"50","author":"Poll","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.bcmd.2016.10.001_bb0280","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/978-1-4614-0650-1_7","article-title":"Glycosphingolipids and insulin resistance","volume":"721","author":"Aerts","year":"2011","journal-title":"Adv. Exp. Med. Biol."},{"issue":"3","key":"10.1016\/j.bcmd.2016.10.001_bb0285","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.bcmd.2007.09.002","article-title":"Overweight, insulin resistance and type II diabetes in type I Gaucher disease patients in relation to enzyme replacement therapy","volume":"40","author":"Langeveld","year":"2008","journal-title":"Blood Cells Mol. Dis."},{"issue":"21","key":"10.1016\/j.bcmd.2016.10.001_bb0290","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1056\/NEJM199105233242104","article-title":"Replacement therapy for inherited enzyme deficiency\u2013macrophage-targeted glucocerebrosidase for Gaucher's disease","volume":"324","author":"Barton","year":"1991","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.bcmd.2016.10.001_bb0295","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1093\/qjmed\/90.1.19","article-title":"Pro-inflammatory cytokines and the pathogenesis of Gaucher's disease: increased release of interleukin-6 and interleukin-10","volume":"90","author":"Allen","year":"1997","journal-title":"QJM"},{"issue":"1","key":"10.1016\/j.bcmd.2016.10.001_bb0300","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.bcmd.2004.08.023","article-title":"Automated system to detect low-grade underlying inflammatory profile: Gaucher disease as a model","volume":"34","author":"Rogowski","year":"2005","journal-title":"Blood Cells Mol. Dis."},{"issue":"3","key":"10.1016\/j.bcmd.2016.10.001_bb0305","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0057507","article-title":"Liver fibrosis in type I Gaucher disease: magnetic resonance imaging, transient elastography and parameters of iron storage","volume":"8","author":"Bohte","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.bcmd.2016.10.001_bb0310","article-title":"Effects of iron and copper overload on the human liver: an ultrastructural study","volume":"1","author":"Fanni","year":"2014","journal-title":"Curr. Med. Chem."},{"issue":"7","key":"10.1016\/j.bcmd.2016.10.001_bb0315","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1002\/ajh.21721","article-title":"Hyperferritinemia and iron overload in type 1 Gaucher disease","volume":"85","author":"Stein","year":"2010","journal-title":"Am. J. Hematol."},{"issue":"2","key":"10.1016\/j.bcmd.2016.10.001_bb0320","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.jhep.2011.02.010","article-title":"A diagnostic approach to hyperferritinemia with a non-elevated transferrin saturation","volume":"55","author":"Adams","year":"2011","journal-title":"J. Hepatol."},{"issue":"1","key":"10.1016\/j.bcmd.2016.10.001_bb0325","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1309\/6L34-V3AR-DW39-DH30","article-title":"Discriminating between iron deficiency anemia and anemia of chronic disease using traditional indices of iron status vs transferrin receptor concentration","volume":"115","author":"Wians","year":"2001","journal-title":"Am. J. Clin. Pathol."},{"issue":"1","key":"10.1016\/j.bcmd.2016.10.001_bb0330","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.bcmd.2012.04.002","article-title":"Ferritinemia during type 1 Gaucher disease: mechanisms and progression under treatment","volume":"49","author":"Mekinian","year":"2012","journal-title":"Blood Cells Mol. Dis."},{"issue":"3","key":"10.1016\/j.bcmd.2016.10.001_bb0335","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/0016-5085(87)90028-X","article-title":"Portal hemodynamics in idiopathic portal hypertension (Banti's syndrome). Comparison with chronic persistent hepatitis and normal subjects","volume":"92","author":"Ohnishi","year":"1987","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1016\/j.bcmd.2016.10.001_bb0340","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1002\/hep.24422","article-title":"Idiopathic noncirrhotic portal hypertension","volume":"54","author":"Schouten","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.bcmd.2016.10.001_bb0345","article-title":"Non-cirrhotic portal hypertension - concept, diagnosis and clinical management","volume":"24","author":"Strauss","year":"2014","journal-title":"Clin. Res. Hepatol. Gastroenterol."},{"issue":"1","key":"10.1016\/j.bcmd.2016.10.001_bb0350","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.bcmd.2005.08.004","article-title":"Increased incidence of cancer in adult Gaucher disease in Western Europe","volume":"36","author":"de Fost","year":"2006","journal-title":"Blood Cells Mol. Dis."},{"issue":"3","key":"10.1016\/j.bcmd.2016.10.001_bb0355","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1615\/CritRevOncog.2013005921","article-title":"Causes of death due to hematological and non-hematological cancers in 57 US patients with type 1 Gaucher disease who were never treated with enzyme replacement therapy","volume":"18","author":"Weinreb","year":"2013","journal-title":"Crit. Rev. Oncog."},{"issue":"2","key":"10.1016\/j.bcmd.2016.10.001_bb0360","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1055\/s-2005-871201","article-title":"Hepatocellular carcinoma in type 1 Gaucher disease: a case report with review of the literature","volume":"25","author":"Xu","year":"2005","journal-title":"Semin. Liver Dis."},{"issue":"3","key":"10.1016\/j.bcmd.2016.10.001_bb0365","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.bcmd.2005.03.004","article-title":"Incidence of malignancies among patients with type I Gaucher disease from a single referral clinic","volume":"34","author":"Zimran","year":"2005","journal-title":"Blood Cells Mol. Dis."},{"issue":"12","key":"10.1016\/j.bcmd.2016.10.001_bb0370","doi-asserted-by":"crossref","first-page":"4569","DOI":"10.1182\/blood-2004-12-4672","article-title":"Gaucher disease and cancer incidence: a study from the Gaucher registry","volume":"105","author":"Rosenbloom","year":"2005","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.bcmd.2016.10.001_bb0375","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1111\/bjh.12335","article-title":"Malignancies and monoclonal gammopathy in Gaucher disease; a systematic review of the literature","volume":"161","author":"Arends","year":"2013","journal-title":"Br. J. Haematol."},{"issue":"32","key":"10.1016\/j.bcmd.2016.10.001_bb0380","doi-asserted-by":"crossref","first-page":"5212","DOI":"10.3748\/wjg.v19.i32.5212","article-title":"MicroRNAs and liver cancer associated with iron overload: therapeutic targets unravelled","volume":"19","author":"Greene","year":"2013","journal-title":"World J. Gastroenterol."},{"issue":"4 Pt 1","key":"10.1016\/j.bcmd.2016.10.001_bb0385","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1016\/0002-9378(95)91494-3","article-title":"Gynecologic and obstetric aspects of Gaucher's disease: a survey of 53 patients","volume":"172","author":"Granovsky-Grisaru","year":"1995","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"3","key":"10.1016\/j.bcmd.2016.10.001_bb0390","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1002\/hep.24199","article-title":"Management of hepatocellular carcinoma: an update","volume":"53","author":"Bruix","year":"2011","journal-title":"Hepatology"},{"issue":"12","key":"10.1016\/j.bcmd.2016.10.001_bb0395","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1007\/s00256-010-0992-3","article-title":"Radiological aspects of Gaucher disease","volume":"40","author":"Katz","year":"2011","journal-title":"Skelet. Radiol."},{"issue":"4","key":"10.1016\/j.bcmd.2016.10.001_bb0400","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1097\/RUQ.0b013e318239c5eb","article-title":"Organ volume by computed tomography correlates with longitudinal axis on ultrasound in patients with Gaucher disease","volume":"27","author":"Elstein","year":"2011","journal-title":"Ultrasound Q."},{"issue":"9","key":"10.1016\/j.bcmd.2016.10.001_bb0405","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1056\/NEJMoa0901249","article-title":"Exposure to low-dose ionizing radiation from medical imaging procedures","volume":"361","author":"Fazel","year":"2009","journal-title":"N. Engl. J. Med."},{"issue":"4","key":"10.1016\/j.bcmd.2016.10.001_bb0410","first-page":"465","article-title":"Endoscopic ultrasound in the diagnosis and treatment of upper digestive bleeding: a useful tool","volume":"22","author":"Seicean","year":"2013","journal-title":"J. Gastrointestin. Liver Dis."},{"issue":"4","key":"10.1016\/j.bcmd.2016.10.001_bb0415","first-page":"1651","article-title":"Introduction to the revised American Association for the Study of Liver Diseases Practice Guideline management of adult patients with ascites due to cirrhosis","volume":"57","author":"BA","year":"2012","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.bcmd.2016.10.001_bb0420","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1586\/egh.12.83","article-title":"Assessing portal hypertension in liver diseases","volume":"7","author":"Berzigotti","year":"2013","journal-title":"Expert Rev. Gastroenterol. Hepatol."},{"issue":"3","key":"10.1016\/j.bcmd.2016.10.001_bb0425","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1002\/hep.22742","article-title":"Liver biopsy","volume":"49","author":"Rockey","year":"2009","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.bcmd.2016.10.001_bb0430","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1097\/MOH.0b013e32835a9148","article-title":"Haematological manifestations and complications of Gaucher disease","volume":"20","author":"Hughes","year":"2013","journal-title":"Curr. Opin. Hematol."},{"issue":"2","key":"10.1016\/j.bcmd.2016.10.001_bb0435","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1002\/hep.21266","article-title":"Thrombin generation in patients with cirrhosis: the role of platelets","volume":"44","author":"Tripodi","year":"2006","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.bcmd.2016.10.001_bb0440","doi-asserted-by":"crossref","first-page":"143","DOI":"10.3109\/09537104.2011.597526","article-title":"Haemostatic abnormalities in treatment-naive patients with type 1 Gaucher's disease","volume":"23","author":"Mitrovic","year":"2012","journal-title":"Platelets"},{"issue":"3","key":"10.1016\/j.bcmd.2016.10.001_bb0445","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1111\/j.1365-2141.2011.08613.x","article-title":"Platelet adhesion defect in type I Gaucher disease is associated with a risk of mucosal bleeding","volume":"153","author":"Spectre","year":"2011","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.bcmd.2016.10.001_bb0450","article-title":"Thromboelastography as a surrogate marker of perisurgical hemostasis in gaucher disease","author":"Ioscovich","year":"2015","journal-title":"Clin. Appl. Thromb. Hemost."},{"issue":"8","key":"10.1016\/j.bcmd.2016.10.001_bb0455","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1016\/j.clinthera.2005.08.004","article-title":"An open-label, noncomparative study of miglustat in type I Gaucher disease: efficacy and tolerability over 24months of treatment","volume":"27","author":"Pastores","year":"2005","journal-title":"Clin. Ther."},{"issue":"1","key":"10.1016\/j.bcmd.2016.10.001_bb0460","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.bcmd.2011.09.009","article-title":"Booster-effect with velaglucerase alfa in patients with Gaucher disease switched from long-term imiglucerase therapy: early access program results from Jerusalem","volume":"48","author":"Elstein","year":"2012","journal-title":"Blood Cells Mol. Dis."},{"issue":"5","key":"10.1016\/j.bcmd.2016.10.001_bb0465","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1182\/blood.V78.5.1183.1183","article-title":"Enzyme replacement therapy for Gaucher disease","volume":"78","author":"Beutler","year":"1991","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.bcmd.2016.10.001_bb0470","doi-asserted-by":"crossref","first-page":"425","DOI":"10.2147\/TCRM.S6865","article-title":"Review of miglustat for clinical management in Gaucher disease type 1","volume":"4","author":"Ficicioglu","year":"2008","journal-title":"Ther. Clin. Risk Manag."},{"issue":"7","key":"10.1016\/j.bcmd.2016.10.001_bb0475","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1001\/jama.2015.459","article-title":"Effect of oral eliglustat on splenomegaly in patients with Gaucher disease type 1: the ENGAGE randomized clinical trial","volume":"313","author":"Mistry","year":"2015","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.bcmd.2016.10.001_bb0480","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1542\/peds.109.6.1170","article-title":"Gaucher's disease and fatal hepatic fibrosis despite prolonged enzyme replacement therapy","volume":"109","author":"Perel","year":"2002","journal-title":"Pediatrics"},{"issue":"3","key":"10.1016\/j.bcmd.2016.10.001_bb0485","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1002\/hep.21907","article-title":"Prevention and management of gastroesophageal varices and variceal hemorrhage in cirrhosis","volume":"46","author":"Garcia-Tsao","year":"2007","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.bcmd.2016.10.001_bb0490","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1002\/hep.26972","article-title":"Evaluation for liver transplantation in adults: 2013 practice guideline by the American Association for the Study of Liver Diseases and the American Society of Transplantation","volume":"59","author":"Martin","year":"2014","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.bcmd.2016.10.001_bb0495","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1097\/00007890-199205000-00031","article-title":"Orthotopic liver transplantation for type 1 Gaucher's disease","volume":"53","author":"DuCerf","year":"1992","journal-title":"Transplantation"},{"issue":"8","key":"10.1016\/j.bcmd.2016.10.001_bb0500","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1111\/j.1600-6143.2010.03168.x","article-title":"Long-term outcomes of liver transplantation in type 1 Gaucher disease","volume":"10","author":"Ayto","year":"2010","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.bcmd.2016.10.001_bb0505","article-title":"Cost Effectiveness of HCV triple therapy with protease inhibitors; the true cost of SVR","volume":"58","author":"Sethi","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.bcmd.2016.10.001_bb0510","article-title":"Effect of thrombocytopenia on treatment tolerability and outcome in chronic hepatitis C patients with advanced hepatic fibrosis receiving (peg)interferon-based antiviral treatment","volume":"58","author":"Maan","year":"2013","journal-title":"Hepatology"},{"issue":"10","key":"10.1016\/j.bcmd.2016.10.001_bb0515","doi-asserted-by":"crossref","first-page":"2595","DOI":"10.3748\/wjg.v20.i10.2595","article-title":"Management of thrombocytopenia due to liver cirrhosis: a review","volume":"20","author":"Hayashi","year":"2014","journal-title":"World J. Gastroenterol."},{"issue":"1","key":"10.1016\/j.bcmd.2016.10.001_bb0520","first-page":"47","article-title":"Platelet IgG antibodies are significantly increased in chronic liver disease","volume":"24","author":"Christodoulou","year":"2011","journal-title":"Ann. Gastroenterol."},{"key":"10.1016\/j.bcmd.2016.10.001_bb0525","doi-asserted-by":"crossref","first-page":"17","DOI":"10.2147\/HMER.S27100","article-title":"The role of eltrombopag in the management of hepatitis C virus-related thrombocytopenia","volume":"5","author":"Danish","year":"2013","journal-title":"Hepat. Med."}],"container-title":["Blood Cells, Molecules, and Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1079979616301218?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1079979616301218?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T12:33:41Z","timestamp":1761050021000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1079979616301218"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2]]},"references-count":105,"alternative-id":["S1079979616301218"],"URL":"https:\/\/doi.org\/10.1016\/j.bcmd.2016.10.001","relation":{},"ISSN":["1079-9796"],"issn-type":[{"value":"1079-9796","type":"print"}],"subject":[],"published":{"date-parts":[[2018,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Liver involvement in Gaucher disease \u2013 Review and clinical approach","name":"articletitle","label":"Article Title"},{"value":"Blood Cells, Molecules, and Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcmd.2016.10.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}